Digital Biomarkers Market Size, Top Countries Data, Industry Share, Company Overview

By Author: Gracy Hill
Total Articles: 1
Comment this article

The Global Digital Biomarkers Market is expected to be valued at USD 10.38 Billion in 2027 from USD 727.8 Million in 2019, registering a CAGR of 39.2% through the estimated period. Owing to the rapidly growing medical cases of various chronic diseases, the market is experiencing exponential growth in recent years. The chronic diseases’ burden is likely to expand by 57.0% in 2020 from the year 2001, as per the World Health Organization (WHO). Developing nations are contributing to nearly 60% of the overall chronic diseases cases.

Recent approaches in psychiatric assessment are consuming considerable time for evaluation and resource-intensive. The development of digital biomarkers is considered for holding huge prospects in allowing scalable, time-sensitive, and affordable psychiatric diagnosis and symptom changes assessment.

Read more@ https://www.emergenresearch.com/industry-report/digital-biomarkers-market

To offer more clarity on the current business environment researchers probe into the import and export status, supply chain management, demand and supply, consumption capability and manufacturing capacity. ...
... When assessing the size of the industry special consideration is given to the value and volume of the products and services offered on a year on year basis. The low cost and the enhanced scalability of advanced biomarkers integrated with smartphones aid in facilitating formerly inaccessible behavioral, social, environmental, and psychological data.

The research provides answers to the following key questions:
• What will be the growth rate of the Digital Biomarkers market for the forecast period, 2020 - 2027? What will be the market size for the estimated period?
• What are the prominent factors driving the Digital Biomarkers market across different regions?
• Who are the major vendors dominating the Digital Biomarkers industry and what are their winning strategies?
• What are the major trends shaping the development of the industry in the coming years?
• What are challenges faced by the Digital Biomarkers market?
• What are potential opportunities for the industry for the forecast period, 2020 - 2027?

Emergen Research has segmented the global digital biomarkers market on the basis of system component, therapeutic area and region:

System Component Outlook (Revenue, USD Billion; 2017-2027)
• Data Collection Tools
o Digital Platforms
o Mobile Apps
o Desktop-Based Software
o Wearable
o Biosensors
• Data Integration Systems

Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
• Cardiovascular Disease
• Sleep and Movement Disease
• Neurodegenerative Disorders
• Psychiatric Disorder
• Gastrointestinal Disease
• Respiratory Disease
• Diabetes
• Others

Regional Outlook (Revenue, USD Billion; 2017-2027)
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o BENELUX
o Rest of Europe
• Asia Pacific
o China
o Japan
o South Korea
o Rest of APAC
• Latin America
o Brazil
o Rest of LATAM
• Middle East & Africa
o Saudi Arabia
o U.A.E.
o Rest of MEA